Risks and methods for peripheral blood progenitor cell collection in small children
- 1 December 2004
- journal article
- review article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 31 (3), 221-231
- https://doi.org/10.1016/j.transci.2004.07.013
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Safety and efficacy of high-dose G-CSF (24 μg/kg) alone for PBSC moblization in childrenBone Marrow Transplantation, 2002
- Granulocyte colony-stimulating factor alone at 12 μg/kg twice a day for 4 days for peripheral blood progenitor cell priming in pediatric patientsBone Marrow Transplantation, 2002
- Long‐Term Hematopoietic Engraftment after Autologous Peripheral Blood Progenitor Cell Transplantation in Pediatric Patients: Effect of the CD34+ Cell DoseVox Sanguinis, 2000
- Granulocyte colony-stimulating factor alone at 20 µg/kg vs. 10 µg/kg for peripheral blood stem cell mobilization in childrenPediatric Transplantation, 2000
- Use of concurrent G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells in children with malignant diseaseBone Marrow Transplantation, 2000
- Mobilization/harvest and transplantation with blood stem cells, manipulated or unmanipulatedPediatric Transplantation, 1999
- Stem cell mobilization with G-CSF alone in breast cancer patients: higher progenitor cell yield by delivering divided doses (2 × 5 μg/kg) compared to a single dose (1 × 10 μg/kg)Bone Marrow Transplantation, 1999
- Granulocyte colony-stimulating factor (G-CSF) dose-dependent efficacy in peripheral blood stem cell mobilization in patients who had failed initial mobilization with chemotherapy and G-CSFBone Marrow Transplantation, 1998
- Effect of CD34+ Selection and Various Schedules of Stem Cell Reinfusion and Granulocyte Colony-Stimulating Factor Priming on Hematopoietic Recovery After High-Dose Chemotherapy for Breast CancerBlood, 1997
- High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.Journal of Clinical Oncology, 1994